Dr. Man Wang | Biomedical Image Analysis and Informatics | Best Researcher Award
Associate Professor at Qingdao University | China
Dr. Man Wang, is an associate professor at Qingdao University in Qingdao, Shandong Province, China, whose research leadership spans deep data mining and analysis, the mechanistic exploration of how non-coding RNAs drive tumor initiation and progression, the molecular and immunological foundations of viral infection-induced tumorigenesis, and the prevention and management strategies of virus-associated diseases, and who has established a significant academic footprint through the publication of 35 peer-reviewed papers as first or corresponding author in high-impact international journals including Molecular Cancer, Frontiers in Immunology, International Journal of Biological Sciences, and Cellular and Molecular Life Sciences, achieving more than 1,500 total citations, with representative studies encompassing influential investigations such as the clinical and immunological characterization of COVID-19 patient outcomes, the relationship between gut microbiota and COVID-19 progression with insights into immune regulation and therapeutic opportunities, the anticancer effects and microbiota-modulating mechanisms of flavonoids, the role of pyroptosis in cardiovascular disease, the origin, formation, and functional roles of extrachromosomal circular DNAs in cancer biology, the emerging clinical significance of exosomal circRNAs in tumor development, the contribution of non-coding RNAs to chemoresistance in hepatocellular carcinoma, and the tumor-promoting activities of specific circular RNAs, including those associated with hepatitis B virus-related liver cancer, thereby positioning Dr. Wang as a prominent scholar advancing molecular oncology, virus-related disease mechanisms, and translational biomedical research while contributing impactful discoveries that bridge clinical relevance with cutting-edge molecular insights.
Featured Publications:
Wang, M., Chang, W., & Zhang, Y. (2025). Artificial intelligence for the diagnosis and management of cancers: Potentials and challenges. MedComm.
Wang, M., Yu, F., & Zhang, Y. (2025). Current status and prospects of artificial intelligence in liver cancer management. Intelligent Oncology.
Wang, M., Chen, X., Yu, F., Zhang, L., Zhang, Y., Chang, W., & Saretzki, G. (2022). The targeting of noncoding RNAs by quercetin in cancer prevention and therapy. Oxidative Medicine and Cellular Longevity.
Ding, H., An, Y., Zhao, T., Liu, B., Wang, Y., Zhang, L., Wang, Y., Zhang, Y., Wang, M., Dong, Y., et al. (2019). Large-scale rapid detection of circulating microRNAs in plasma for diagnosis and screening of specific diseases. Nanoscale.
Wang, M., Jiang, S., Zhang, Y., Li, P., & Wang, K. (2019). The multifaceted roles of pyroptotic cell death pathways in cancer. Cancers.